Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00539240 · ClinicalTrials.gov registry record · Phase 2
Role of Pain Modulation in GERD Patients Who Failed Standard Dose PPI
A Phase 2 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
- 236
- Enrollment target
NCT00539240 is a Phase 2 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 236 participants.
The verdict
NCT00539240, a Phase 2 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 236 participants
- Enrollment target
Study Summary
The purpose of this project is to compare the efficacy (how successful) 1) standard-dose proton pump inhibitor (PPI) (rabeprazole 20 mg once daily) (a medication that completely blocks the stomach from producing acid) plus low dose tricyclic antidepressant (nortriptyline 50mg) (TCA); 2) double-dose PPI (rabeprazole 20 mg twice a day); to 3) standard-dose PPI (rabeprazole 20mg once daily) and placebo (an inactive substance, like a sugar pill) to determine the relative symptom resolution and health-related quality of life in gastroesophageal reflux disease (a disease characterized by a burning sensation (heartburn) behind the breast bone caused by a backflow of stomach contents into the esophagus) (GERD) patients who fail standard-dose PPI and you will be randomly assigned (similar to flipping a coin) to one of the three groups.
Interventions
- DRUG Rabeprazole 20mg, placebo dinner and bedtime
- DRUG Rabeprazole 20 mg two times, Placebo at bedtime
- DRUG Rabeprazole 20mg,placebo dinner ,Low dose Tricyclic Antidepressant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 236 participants |
| Start Date | 2006-04 |
| Est. Completion | 2011-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00539240
The ClinicalTrials.gov registry entry for NCT00539240 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 236 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Rabeprazole 20mg, placebo dinner and bedtime is the first listed.
NCT00539240 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00539240 about?
NCT00539240 is a clinical study titled "Role of Pain Modulation in GERD Patients Who Failed Standard Dose PPI". The purpose of this project is to compare the efficacy (how successful) 1) standard-dose proton pump inhibitor (PPI) (rabeprazole 20 mg once daily) (a medication that completely blocks the stomach from producing acid) plus low dose tricyclic antidepressant (nortriptyline 50mg) (TCA); 2) double-dose ...
What is the current status of trial NCT00539240?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 236 participants. The study started on 2006-04. Estimated completion is 2011-11.
What interventions are being tested in trial NCT00539240?
The interventions under investigation include: Rabeprazole 20mg, placebo dinner and bedtime (DRUG), Rabeprazole 20 mg two times, Placebo at bedtime (DRUG), Rabeprazole 20mg,placebo dinner ,Low dose Tricyclic Antidepressant (DRUG).
Who is sponsoring clinical trial NCT00539240?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.